Methotrexate vs Trastuzumab
Methotrexate vs Trastuzumab: Overview
This comparison examines the pharmacological differences between Methotrexate and Trastuzumab.
Mechanism of Action
Methotrexate: Dihydrofolate reductase inhibitor.
Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.
Pharmacokinetics
Half-life: Methotrexate β 3-10 hours; Trastuzumab β 28 days.
Chemical Properties
Molecular Formula: Methotrexate β C20H22N8O5.
Molecular Weight: Methotrexate β 454.4400 g/mol.
Type: Methotrexate β Small molecule; Trastuzumab β Antibody.